Compounds > (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Vomiting

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid has been researched along with Vomiting* in 1 studies

Other Studies

1 other study(ies) available for (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Vomiting

ArticleYear
Rhabdomyolysis secondary to hyponatraemia.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:4

    Topics: Aged; Brain Ischemia; Consciousness Disorders; Dehydration; Diarrhea; Dyslipidemias; Fatty Acids, Monounsaturated; Female; Fluid Therapy; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyponatremia; Indoles; Internal Capsule; Natriuresis; Rhabdomyolysis; Sodium Chloride; Thalamus; Vomiting

2011